American Shared Hospital Services (NYSE MKT:AMS) announced today that Ernest A. Bates, M.D. and Craig K. Tagawa will be presenting on behalf of the company at the Sidoti & Company Fall 2016 Emerging Growth Convention in New York City.


Sidoti & Company Fall 2016 Emerging Growth Convention


Tuesday, November 1, 2016


New York Marriott Marquis - 5 th Floor

1535 Broadway, New York, NY 10036

The company is scheduled to deliver a presentation at 10:25 am EST. Investors interested in attending and scheduling a one-on-one meeting with management should click the link here.

About the Sidoti & Company Emerging Growth Convention

The Sidoti & Company Fall 2016 Emerging Growth Convention will focus on companies with market capitalizations of $600 million and less, connecting their executive management teams with institutional and high-net-worth investors while building interest and visibility into the most overlooked, undervalued segment of the equity market.

About Sidoti & Company, LLC

Sidoti & Company, founded in 1999, is Wall Street's preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. Sidoti & Company's approach affords institutional investor clients a combination of high-quality research of over 250 companies, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. Sidoti & Company serves nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. They also host a biannual Emerging Growth Convention in New York, and is a provider of company sponsored research. For more information, please refer to Sidoti & Company

About AMS

American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers proton therapy, the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century SM concept. AMS owns a common stock investment in Mevion Medical Systems, Inc., developer of the compact MEVION S250 Proton Therapy System.

View source version on

Copyright Business Wire 2010